锦波生物
(832982)
| 流通市值：54.47亿 | | | 总市值：156.75亿 |
| 流通股本：3075.59万 | | | 总股本：8851.18万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 572,006,323.2 | 518,547,584.74 | 461,982,053.16 | 182,079,536.14 |
| 应收票据及应收账款 | 133,170,924.82 | 129,160,851.37 | 108,306,630.67 | 123,066,786.92 |
| 其中：应收票据 | 14,351,861.49 | 2,284,000 | - | - |
| 应收账款 | 118,819,063.33 | 126,876,851.37 | 108,306,630.67 | 123,066,786.92 |
| 应收款项融资 | - | - | 5,710,000 | - |
| 预付款项 | 24,376,013.45 | 18,169,465.75 | 20,727,673.98 | 16,402,836.96 |
| 其他应收款合计 | 4,459,689.5 | 4,050,600.69 | 4,238,477.66 | 1,946,791.29 |
| 存货 | 70,057,666.5 | 66,285,840.69 | 72,617,446.38 | 57,091,242.81 |
| 其他流动资产 | 17,270,970.93 | 16,372,853.73 | 13,543,427.3 | 7,066,777.75 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 821,341,588.4 | 752,587,196.97 | 687,125,709.15 | 387,653,971.87 |
| 非流动资产: | | | | |
| 固定资产 | 355,299,868.18 | 361,089,618.01 | 360,999,332.64 | 365,251,768.43 |
| 在建工程 | 130,783,698.6 | 131,901,375.85 | 123,293,119.05 | 59,964,326.85 |
| 使用权资产 | 92,208,450.6 | 92,976,094.77 | 96,780,088.27 | 104,467,873.55 |
| 无形资产 | 23,950,613.2 | 25,150,243.31 | 26,209,765.02 | 18,671,534.16 |
| 开发支出 | 50,301,794.09 | 25,960,499.73 | 18,441,827.31 | 22,853,114.1 |
| 长期待摊费用 | 19,849,290.02 | 20,774,889.66 | 15,320,214.54 | 14,933,018.11 |
| 递延所得税资产 | 13,742,414.48 | 12,952,433.64 | 12,498,644.1 | 12,139,694.23 |
| 其他非流动资产 | 18,001,085.73 | 11,146,020.04 | 18,177,497.13 | 17,020,843.97 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 704,137,214.9 | 681,951,175.01 | 671,720,488.06 | 615,302,173.4 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,525,478,803.3 | 1,434,538,371.98 | 1,358,846,197.21 | 1,002,956,145.27 |
| 流动负债: | | | | |
| 短期借款 | 59,656,927.91 | 69,182,103.63 | 69,682,064.99 | 61,240,741.05 |
| 应付票据及应付账款 | 60,951,311.58 | 54,498,239.46 | 79,269,846.13 | 47,151,414.86 |
| 应付账款 | 60,951,311.58 | 54,498,239.46 | 79,269,846.13 | 47,151,414.86 |
| 合同负债 | 39,325,062.94 | 24,778,964.09 | 27,848,649.39 | 32,872,093.82 |
| 应付职工薪酬 | 22,911,135.9 | 33,744,370.01 | 16,239,086.71 | 14,518,547.5 |
| 应交税费 | 20,647,681.5 | 27,811,769.96 | 19,823,097.47 | 14,298,133.89 |
| 其他应付款合计 | 16,852,207.48 | 16,472,048.79 | 49,918,337.19 | 14,699,613.01 |
| 其中:应付利息 | - | - | 966,306.84 | 966,306.84 |
| 应付股利 | - | - | 34,043,000 | - |
| 一年内到期的非流动负债 | 26,436,486.89 | 32,492,666.88 | 29,633,967.38 | 37,476,297.63 |
| 其他流动负债 | 1,859,236.53 | 3,333,589.04 | 1,496,519.72 | 919,981.75 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 248,640,050.73 | 262,313,751.86 | 293,911,568.98 | 223,176,823.51 |
| 非流动负债: | | | | |
| 长期借款 | 29,666,449.26 | 30,884,242.15 | 34,661,082.76 | 42,730,613.45 |
| 租赁负债 | 123,556,079.18 | 119,956,197.16 | 118,992,894.3 | 119,876,325.56 |
| 递延收益 | 62,456,069.59 | 61,520,047.31 | 63,616,277.8 | 65,772,702.1 |
| 递延所得税负债 | 1,660,519.87 | 1,732,930.65 | 1,805,341.41 | 1,877,752.19 |
| 其他非流动负债 | 5,000,000 | 5,000,000 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 222,339,117.9 | 219,093,417.27 | 219,075,596.27 | 230,257,393.3 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 470,979,168.63 | 481,407,169.13 | 512,987,165.25 | 453,434,216.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 68,086,000 | 68,086,000 | 68,086,000 | 62,336,000 |
| 资本公积 | 330,831,959.4 | 330,831,959.4 | 330,837,840.13 | 88,876,055.69 |
| 盈余公积 | 34,043,000 | 34,043,000 | 31,168,000 | 31,168,000 |
| 未分配利润 | 622,082,212.65 | 520,712,396.75 | 416,065,843.5 | 367,266,137.79 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,055,043,172.05 | 953,673,356.15 | 846,157,683.63 | 549,646,193.48 |
| 少数股东权益 | -543,537.38 | -542,153.3 | -298,651.67 | -124,265.02 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,054,499,634.67 | 953,131,202.85 | 845,859,031.96 | 549,521,928.46 |
| 负债和股东权益合计 | 1,525,478,803.3 | 1,434,538,371.98 | 1,358,846,197.21 | 1,002,956,145.27 |
| 公告日期 | 2024-04-22 | 2024-03-20 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |